Fluid-based biomarker testing that helps patients and care teams guide treatment and watch for changes.
Consented intake · your records travel with you · nothing moves without your sign-off
Infiniplex offers liquid biopsy testing that gathers and analyzes blood and other bodily fluids, such as urine, bone marrow aspirate, and saliva, for biomarkers including DNA, RNA, and proteins. It supports treatment guidance, minimum residual disease monitoring, and early detection, giving patients distinctive biomarker data to inform their care.
Prefer the source? Infiniplex's own site has more.
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Infiniplex handles billing.
We don't have confirmed insurance details for Infiniplex yet. Start a coverage check with your plan, or contact the provider directly.
Answers grounded in Infiniplex's details here. Educational only; your oncologist directs treatment.
Powered by Navis on opencancer.ai
Other providers in similar categories.
Gather distinctive biomarkers that can guide treatment and monitor disease progression
FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Finds clinical trials you actually qualify for — matched to your tumor's biomarkers and treatment history, not a generic keyword search.
This page is general information. Upload your records for analysis specific to YOUR diagnosis.